Adipose Stromal Cell Spheroids for Cartilage Repair: A Promising Tool for Unveiling the Critical Maturation Point.

adipose stromal cells chondrogenesis deep imaging mass density spheroids

Journal

Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056

Informations de publication

Date de publication:
12 Oct 2023
Historique:
received: 20 09 2023
revised: 09 10 2023
accepted: 10 10 2023
medline: 28 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

Articular cartilage lacks intrinsic regenerative capabilities, and the current treatments fail to regenerate damaged tissue and lead only to temporary pain relief. These limitations have prompted the development of tissue engineering approaches, including 3D culture systems. Thanks to their regenerative properties and capacity to recapitulate embryonic processes, spheroids obtained from mesenchymal stromal cells are increasingly studied as building blocks to obtain functional tissues. The aim of this study was to investigate the capacity of adipose stromal cells to assemble in spheroids and differentiate toward chondrogenic lineage from the perspective of cartilage repair. Spheroids were generated by two different methods (3D chips vs. Ultra-Low Attachment plates), differentiated towards chondrogenic lineage, and their properties were investigated using molecular biology analyses, biophysical measurement of mass density, weight, and size of spheroids, and confocal imaging. Overall, spheroids showed the ability to differentiate by expressing specific cartilaginous markers that correlate with their mass density, defining a critical point at which they start to mature. Considering the spheroid generation method, this pilot study suggested that spheroids obtained with chips are a promising tool for the generation of cartilage organoids that could be used for preclinical/clinical approaches, including personalized therapy.

Identifiants

pubmed: 37892912
pii: bioengineering10101182
doi: 10.3390/bioengineering10101182
pmc: PMC10603958
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca Sanitaria del cinque per mille 2020
Organisme : Ministry of Economic Development
ID : Project Nr F/200110/01-03/X45-CUP B61B19000580008

Références

Nanomedicine. 2020 Oct;29:102253
pubmed: 32619705
J Cell Physiol. 2015 Jan;230(1):16-26
pubmed: 24912145
Int J Mol Sci. 2018 Apr 25;19(5):
pubmed: 29693604
Nat Rev Mol Cell Biol. 2006 Mar;7(3):211-24
pubmed: 16496023
Acta Biomater. 2018 Jan;65:1-20
pubmed: 29128537
Front Immunol. 2020 Dec 23;11:564887
pubmed: 33424829
World J Stem Cells. 2020 Feb 26;12(2):110-122
pubmed: 32184936
Bull Exp Biol Med. 2021 Feb;170(4):528-536
pubmed: 33725253
Biomaterials. 2014 Feb;35(6):1914-23
pubmed: 24331712
Future Sci OA. 2021 Dec 06;8(2):FSO774
pubmed: 35070356
Maturitas. 2014 Jul;78(3):188-98
pubmed: 24855933
Birth Defects Res C Embryo Today. 2009 Dec;87(4):351-71
pubmed: 19960542
Osteoarthritis Cartilage. 2013 Dec;21(12):1904-12
pubmed: 24455780
Bioengineering (Basel). 2018 Jun 19;5(2):
pubmed: 29921755
Front Physiol. 2017 Feb 02;8:50
pubmed: 28210226
Biomaterials. 2015 Dec;71:24-34
pubmed: 26318814
Micromachines (Basel). 2020 Apr 28;11(5):
pubmed: 32354148
Tissue Eng Part A. 2013 Feb;19(3-4):484-96
pubmed: 23088537
Bioengineering (Basel). 2023 Feb 02;10(2):
pubmed: 36829683
Ageing Res Rev. 2008 Apr;7(2):106-13
pubmed: 18054526
Tissue Eng Part B Rev. 2014 Oct;20(5):365-80
pubmed: 24168395
J R Soc Interface. 2017 Feb;14(127):
pubmed: 28202590
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14843-8
pubmed: 23980147
Nat Methods. 2006 May;3(5):369-75
pubmed: 16628207
Int J Mol Sci. 2022 Feb 25;23(5):
pubmed: 35269672
Stem Cells Int. 2016;2016:9176357
pubmed: 26649054
Rejuvenation Res. 2004 Summer;7(2):134-45
pubmed: 15312300
Drug Discov Today Technol. 2017 Mar;23:27-36
pubmed: 28647083
Organogenesis. 2008 Jan;4(1):28-32
pubmed: 19279712
J Biomol Screen. 2006 Dec;11(8):922-32
pubmed: 16973921
Methods Mol Biol. 2013;986:253-66
pubmed: 23436417
PLoS One. 2021 Jun 8;16(6):e0252907
pubmed: 34101765
Trends Biotechnol. 2017 Feb;35(2):133-144
pubmed: 27634310

Auteurs

Azzurra Sargenti (A)

CellDynamics iSRL, 40136 Bologna, Italy.

Simone Pasqua (S)

CellDynamics iSRL, 40136 Bologna, Italy.

Marco Leu (M)

abc biopply ag, 4500 Solothurn, Switzerland.

Laura Dionisi (L)

CellDynamics iSRL, 40136 Bologna, Italy.

Giuseppe Filardo (G)

Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Brunella Grigolo (B)

Laboratorio RAMSES, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Daniele Gazzola (D)

CellDynamics iSRL, 40136 Bologna, Italy.

Spartaco Santi (S)

Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", Unit of Bologna, CNR, 40136 Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Carola Cavallo (C)

Laboratorio RAMSES, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Classifications MeSH